NCT04467281 2022-07-01
A Study of PET/CT Scans With the Radioactive Tracer 89Zr-DFO-Daratumumab in People With Myeloma
Memorial Sloan Kettering Cancer Center
Phase 2 Withdrawn
Memorial Sloan Kettering Cancer Center
Memorial Sloan Kettering Cancer Center
Rigshospitalet, Denmark